News & Events

Show:
March 21, 2022

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer

Crinetics ($CRNX) appointed Chris Robillard to the role of chief business officer. Mr. Robillard is an expert in designing and...

READ MORE
March 14, 2022

Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors

Crinetics ($CRNX) today announced the appointment of Caren Deardorf to the company’s board of directors. Ms. Deardorf previously led commercial...

READ MORE
March 10, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals ($CRNX) announced that the Compensation Committee granted non-qualified stock option awards to fivenew non-executive employees

READ MORE
March 1, 2022

Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer

Crinetics ($CRNX) today announced the appointment of James Hassard as chief commercial officer. Mr. Hassard is a commercial leader with...

READ MORE
February 28, 2022

Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan

Crinetics Pharmaceuticals ($CRNX) and Sanwa Kagaku Kenkyusho Co., Ltd. have entered into a strategic partnership to develop and commercialize paltusotine...

READ MORE
February 9, 2022

Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference

Crinetics Pharmaceuticals ($CRNX) will participate in a fireside chat at the annual SVB Leerink Global Healthcare Conference on February 16...

READ MORE
February 9, 2022

SVB Leerink Global Healthcare Conference

Event Date: February 16, 2022

READ MORE
February 1, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals ($CRNX) announced that the Compensation Committee granted non-qualified stock option awards to seven new non-executive employees

READ MORE
January 12, 2022

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 40th Annual J.P. Morgan Healthcare Conference 

Crinetics Pharmaceuticals ($CRNX) will provide a company update at the 40th annual J.P. Morgan Healthcare Conference today, Wednesday, January 12th...

READ MORE
January 10, 2022

40th Annual J.P. Morgan Healthcare Conference 

Event Date: January 12, 2022

READ MORE